Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010-2016.

Conclusion: These findings may be of use to TB clinicians in the province by informing the initial empiric antibiotic regimen prescribed while awaiting phenotypic drug susceptibility testing and assisting in decisions regarding whether to request rapid molecular drug susceptibility testing. PMID: 32281986 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32281986?dopt=Abstract

Source: Can Commun Dis Rep - April 1, 2020 Category: Infectious Diseases Authors: Hirama T, Sabur N, Derkach P, McNamee J, Song H, Marras T, Brode S Tags: Can Commun Dis Rep Source Type: research